Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
halothane | Solution | 250 mL | |
ketamine | Injection | 50 mg (as hydrochloride)/mL in 10-mL vial | |
nitrous oxide | Inhalation | N/A | |
oxygen | Inhalation (medicine gas) | N/A | |
propofol | Aqueous emulsion | 200 mg/ 20 ml | |
thiopental | Powder for injection | 0.5 g (as sodium) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
bupivacaine | Solution for injection | 5 mg/ml | |
bupivacaine + glucose | Injection | 0.5%/ 80 mg/ml | |
ephedrine | Injection | 50 mg/ml | |
lidocaine | Injection | 2% (hydrochloride) in 2 mL ampoule | |
lidocaine | Ointment | 5% (hydrochloride) | |
lidocaine + epinephrine (adrenaline) | Dental cartridge | 2% (hydrochloride) + epinephrine 1:80 000 | |
lidocaine + epinephrine (adrenaline) | Injection | 2% / 1:100 000 |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
atropine | Injection | 250 mcg/mL | |
diazepam | Injection | 10 mg in 2-mL ampoule | |
fentanyl | Injection | 50 mcg (citrate)/mL | |
midazolam | Injection | 15 mg/3 ml | |
morphine | Injection | 10 mg/ml | |
promethazine | Injection | 25mg (hydrochloride)/ml | |
promethazine | Oral solution | 1mg/mL | |
promethazine | Tablet | 25 mg | |
sufentanil | Injection | 50 mcg/mL (5 mL) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
diclofenac | Injection | 25 mg (sodium)/mL | |
diclofenac | Suppository | 100 mg (as sodium) | |
ibuprofen | Tablet | 200 mg | |
ibuprofen | Tablet | 400 mg | |
methylsalicylate | Ointment | 10% | |
naproxen | Tablet | 250 mg | |
paracetamol | Oral liquid | 120 mg/5 mL | |
paracetamol | Suppository | 1 g | |
paracetamol | Suppository | 120 mg | |
paracetamol | Suppository | 240 mg | |
paracetamol | Suppository | 500 mg | |
paracetamol | Tablet | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
codeine | Tablet | 30 mg | |
fentanyl | Patch | 100 mcg/hr | |
fentanyl | Patch | 12 mcg/hr | |
fentanyl | Patch | 25 mcg/hr | |
morphine | Oral liquid | 2 mg/mL (hydrochloride) | |
morphine | Solid oral dosage form | 10 mg | |
morphine | Tablet (controlled release) | 10 mg | |
morphine | Tablet (controlled release) | 30 mg | |
morphine | Tablet (controlled release) | 60 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
allopurinol | Tablet | 100 mg | |
allopurinol | Tablet | 300 mg | |
colchicine | Tablet | 0.5mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
azathioprine | Tablet | 50 mg | |
ciclosporin | Capsule | 25 mg | |
ciclosporin | Capsule | 50 mg | |
hydroxychloroquine | Tablet | 200 mg | |
methotrexate | Tablet | 2.5 mg | |
penicillamine | Capsule | 250 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cetirizine | Tablet | 10 mg | |
chlorphenamine | Injection | 10 mg (hydrogen maleate) in 1-ml ampoule | |
chlorphenamine | Oral liquid | 2 mg/5 ml (hydrogen maleate) | |
chlorphenamine | Tablet | 4 mg (hydrogen maleate) | |
cinnarizine | Tablet | 25 mg | |
dexamethasone | Injection | 4 mg (phosphate)/mL | |
dexamethasone | Tablet | 0.5 mg | |
dexamethasone | Tablet | 1 mg | |
epinephrine (adrenaline) | Injection | 1 mg in 1-mL ampoule | |
hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
prednisolone | Tablet | 30 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
atropine | Injection | 1 mg (sulfate) in 1-ml ampoule | |
calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
deferoxamine | Powder for injection | 500 mg | |
methylthioninium chloride (methylene blue) | Injection | 10 mg/ml in 10-ml ampoule | |
naloxone | Injection | 400 mcg (hydrochloride) in 1-mL ampoule | |
penicillamine | Capsule | 250 mg | |
potassium ferric hexacyano-ferrate(II) - 2H20 (Prussian blue) | Powder for oral administration | N/A | |
pralidoxime | Injection | 200 mg/mL (mesilate) | |
sodium calcium edetate | Injection | 200 mg/ml in 5-ml ampoule | |
sodium nitrite | Injection | 30 mg/mL in 10-mL ampoule | |
sodium thiosulfate | Injection | 250 mg/mL in 50-mL ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
carbamazepine | Tablet (chewable) | 100 mg | |
carbamazepine | Tablet (chewable) | 200 mg | |
clonazepam | Tablet | 2mg | |
diazepam | Injection | 10 mg in 2-mL ampoule | |
magnesium sulfate | Injection | 200 mg/mL in 10-mL ampoule | |
phenobarbital | Tablet | 100 mg | |
phenobarbitone | Injection | 100 mg/mL | |
phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
valproic acid (sodium valproate) | Oral liquid | 60 mg/mL | |
valproic acid (sodium valproate) | Tablet (controlled release) | 300 mg (enteric coated) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
albendazole | Tablet (chewable) | 400 mg | |
ivermectin | Tablet | 3 mg | |
mebendazole | Tablet | 100 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
praziquantel | Tablet | 600 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amoxicillin | Suspension | 125 mg/ 5 ml | |
amoxicillin | Suspension | 250 mg/5ml | |
amoxicillin | Tablet | 500 mg | |
amoxicillin | Tablet | 500 mg | |
amoxicillin + clavulanic acid | Powder for injection | 1g + 0.2g | |
amoxicillin + clavulanic acid | Powder for injection | 500mg/ 50 mg | |
ampicillin | Powder for injection | 1 g | |
ampicillin | Powder for injection | 500 mg | |
benzathine benzylpenicillin | Injection | 2 400 000 IU | |
benzathine benzylpenicillin | Powder for injection | 1 200 000 UI | |
benzylpenicillin | Powder for injection | 1 million IU | |
flucloxacillin | Oral liquid | 125 mg/5 mL (sodium salt) | |
flucloxacillin | Oral liquid | 250mg/5ml (sodium salt) | |
flucloxacillin | Powder for injection | 500 mg | |
flucloxacillin | Tablet | 500 mg | |
phenoxymethylpenicillin | Tablet | 250 mg (as potassium salt) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amikacin | Injection | 250 mg/mL in 2-mL vial | |
azithromycin | Tablet | 250 mg | |
cefazolin | Injection | 1g | |
cefotaxime | Powder for injection | 250 mg | |
ceftriaxone | Powder for injection | 1 g (as sodium salt) in vial | |
ceftriaxone | Powder for injection | 2 g (as sodium) in vial | |
ceftriaxone | Powder for injection | 250 mg (as sodium salt) in vial | |
ceftriaxone | Powder for injection | 500 mg | |
ciprofloxacin | Tablet | 250 mg | |
ciprofloxacin | Tablet | 500 mg | |
co-trimoxazole | Injection | 96 mg/ml x 5 ml IV | |
co-trimoxazole | Suspension | 240 mg/5 ml | |
co-trimoxazole | Tablet | 480 mg | |
doxycycline | Tablet | 100mg | |
erythromycin | Oral suspension | 125 mg/5 mL (ethylsuccinate) | |
erythromycin | Powder for injection | 1 g (lactiobonate) | |
erythromycin | Tablet | 250 mg | |
gentamicin | Injection | 10 mg (sulfate)/mL in 2-mL vial | |
gentamicin | Injection | 40 mg (sulfate)/ml in 2-mL vial | |
meropenem | Powder for injection | 500mg | |
metronidazole | Injection | 500 mg in 100-mL vial | |
metronidazole | Suspension | 200 mg/ 5 ml | |
neomycin | Solid oral dosage form | 250 mg (sulfate) | |
nitrofurantoin | Tablet | 100 mg | |
nitrofurantoin | Tablet | 50mg | |
spectinomycin | Powder for injection | 2 g (as hydrochloride) in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
clofazimine | Solid oral dosage form | 100 mg | |
clofazimine | Solid oral dosage form | 50 mg | |
dapsone | Tablet | 100 mg | |
dapsone | Tablet | 50 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ethambutol | Tablet | 400mg | |
ethambutol + isoniazid + pyrazinamide + rifampicin | Tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
ethambutol + isoniazid + rifampicin | Tablet | 275 mg + 75 mg + 150 mg | |
isoniazid | Tablet | 100mg | |
isoniazid | Tablet | 300mg | |
isoniazid + rifampicin | Tablet | 150 mg + 300 mg | |
isoniazid + rifampicin | Tablet | 75 mg + 150 mg | |
pyrazinamide | Tablet | 500 mg | |
rifampicin | Oral liquid | 20 mg/ml | |
rifampicin | Solid oral dosage form | 150 mg | |
rifampicin | Solid oral dosage form | 300 mg | |
streptomycin | Powder for injection | 1 g |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amphotericin B | Powder for injection | 50 mg in vial | |
fluconazole | Tablet | 200 mg | |
flucytosine | Capsule | 250 mg | |
griseofulvin | Tablet | 125 mg | |
griseofulvin | Tablet | 500mg | |
ketoconazole | Tablet | 200 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
metronidazole | Tablet | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
pentamidine | Powder for injection | 300 mg (isetionate) in ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
artemether + lumefantrine | Tablet | 20 mg + 120 mg | |
artesunate | Injection | ampoules, containing 60 mg anhydrous artesunic acid with a separate ampoule of 5% sodium bicarbonate solution | |
artesunate | Tablet | 100 mg | |
doxycycline | Tablet | 100mg | |
mefloquine | Tablet | 250 mg (hydrochloride) | |
primaquine | Tablet | 15 mg (as diphosphate) | |
primaquine | Tablet | 7.5 mg (as diphosphate) | |
quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
abacavir | Suspension | 20 mg/ml x 240 ml | |
abacavir | Tablet | 300 mg | |
efavirenz (EFV or EFZ) | Tablet | 600 mg | |
efavirenz (EFV or EFZ) | Tablet (scored) | 200 mg | |
lamivudine (3TC) | Oral solution | 10mg/mL (100mL) | |
lamivudine (3TC) | Oral solution | 10mg/mL (240mL) | |
lamivudine (3TC) | Tablet | 150 mg | |
lamivudine + nevirapine + stavudine | Tablet | 150 mg + 200 mg + 30 mg | |
lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
lopinavir + ritonavir (LPV/r) | Capsule | 133.3 mg + 33.3 mg | |
lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
nevirapine (NVP) | Suspension | 10mg/ml | |
nevirapine (NVP) | Tablet | 200 mg | |
stavudine (d4T) | Tablet | 30 mg | |
tenofovir | Tablet | 300 mg | |
zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL (100 mL) | |
zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL (300 mL) | |
zidovudine (ZDV or AZT) | Solid oral dosage form | 100 mg | |
zidovudine (ZDV or AZT) | Solid oral dosage form | 300 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
benznidazole | Tablet | 100 mg | |
benznidazole | Tablet | 50 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylsalicylic acid | Tablet | 500 mg | |
paracetamol | Tablet | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
propranolol | Tablet | 40 mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
azathioprine | Tablet | 50 mg | |
ciclosporin | Capsule | 25 mg | |
ciclosporin | Capsule | 50 mg | |
methylprednisolone | Injection | 40 mg/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
all trans retinoid acid (ATRA) | Capsule | 10 mg | |
asparaginase | Powder for injection | 10 000 IU in vial | |
bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
capecitabine | Tablet | 150 mg | |
capecitabine | Tablet | 500 mg | |
chlorambucil | Tablet | 2 mg | |
chlormethine | Powder for injection | 10 mg | |
cisplatin | Powder for injection | 10 mg in vial | |
cyclophosphamide | Powder for injection | 200 mg | |
cyclophosphamide | Powder for injection | 500 mg in vial | |
cytarabine | Powder for injection | 100 mg in vial | |
dacarbazine | Powder for injection | 200 mg | |
dactinomycin | Powder for injection | 500 mcg in vial | |
docetaxel | Injection | 20 mg/ml | |
doxorubicin | Powder for injection | 10 mg in vial | |
doxorubicin | Powder for injection | 50 mg in vial | |
etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
fluorouracil | Injection | 50 mg/ml in 5-ml ampoule | |
mercaptopurine | Tablet | 50 mg | |
methotrexate | Injection | L.P.F 25MG/ML X 2ML | |
methotrexate | Tablet | 2.5 mg (as sodium salt) | |
oxaliplatin | Injection | 100 mg/ 20 ml in 20 ml vial | |
oxaliplatin | Injection | 50 mg/ 10 ml in 10 ml vial | |
paclitaxel | Powder for injection | 6 mg/ml | |
procarbazine | Capsule | 50 mg (as hydrochloride) | |
thalidomide | Solid oral dosage form | 100 mg | |
vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
vincristine | Injection | 1 mg/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
calcium folinate | Injection | 10 mg/mL | |
calcium folinate | Tablet | 15 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
anastrozole | Tablet | 1mg | |
bicalutamide | Tablet | 150 mg | |
bicalutamide | Tablet | 50 mg | |
conjugated estrogens | Tablet | 1.25 mg | |
dexamethasone | Injection | 4 mg (phosphate)/mL | |
dexamethasone | Solid oral dosage form | 1.5 mg | |
medroxyprogesterone acetate | Tablet | 100 mg | |
prednisolone | Tablet | 30 mg | |
prednisolone | Tablet | 5 mg | |
tamoxifen | Tablet | 20 mg (as citrate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
hydroxycarbamide | Solid oral dosage form | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
biperiden | Tablet | 2 mg (hydrochloride) | |
levodopa + carbidopa | Tablet | 100 mg/ 25 mg | |
levodopa + carbidopa | Tablet | 200 mg/ 50 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ferrous fumarate | Oral liquid | 6 mg/mL | |
ferrous fumarate | Tablet | 200 mg | |
folic acid | Tablet | 0.5mg | |
hydroxocobalamin | Injection | 1 mg/mL | |
hydroxycarbamide | Solid oral dosage form | 500 mg | |
iron + dextran complex | Injection | 50 mg/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
desmopressin | Nasal spray | 0.1 mg (acetate)/mL | |
heparin sodium | Injection | 5000 IU/mL in 5-mL vial | |
nadroparina | Injection | 9500 IU Anti-Xa/ml (0.3ml) | |
phenprocoumon | Tablet | 3 mg | |
phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
phytomenadione | Injection | 2 mg/ml | |
phytomenadione | Tablet | 10 mg | |
protamine sulfate | Injection | 10 mg/mL in 5-mL ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
polygeline | Injection | 3.5% in 500ml vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
albumin | Injection | 20% | |
anti-D immunoglobulin (human) | Injection | 500 IU | |
factor IX | N/A | N/A | |
factor VIII | Solution for injection | 500 UI | |
plasma protein fraction | Injection | 4% (100mL) Pasteurized |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
bisoprolol | Tablet | 1.25 mg | |
bisoprolol | Tablet | 2.5 mg | |
bisoprolol | Tablet | 5 mg | |
isosorbide dinitrate | Tablet (prolonged release) | 20 mg | |
isosorbide dinitrate | Tablet (sublingual) | 5 mg | |
verapamil | Tablet | 40 mg (hydrochloride) | |
verapamil | Tablet | 80 mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amiodarone | Injection | 50 mg/mL in 3-mL ampoule (hydrochloride) | |
amiodarone | Tablet (HCI) | 200 mg (hydrochloride) | |
bisoprolol | Tablet | 1.25 mg | |
bisoprolol | Tablet | 2.5 mg | |
bisoprolol | Tablet | 5 mg | |
digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
digoxin | Oral liquid | 50 micrograms/mL | |
digoxin | Tablet | 250 mcg | |
digoxin | Tablet | 62.5 micrograms | |
isoprenaline | Injection | 1 mg/mL | |
lidocaine | Injection | 1% (hydrochloride) | |
procainamide | Injection | 100 mg (hydrochloride)/mL | |
sotalol | Tablet | 80 mg | |
verapamil | Injection | 2.5 mg (hydrochloride)/mL in 2-mL ampoule | |
verapamil | Tablet (prolonged release) | 120 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amlodipine | Tablet | 10 mg | |
amlodipine | Tablet | 5 mg | |
bisoprolol | Tablet | 1.25 mg | |
bisoprolol | Tablet | 2.5 mg | |
bisoprolol | Tablet | 5 mg | |
enalapril | Tablet | 20 mg | |
enalapril | Tablet | 5 mg | |
hydralazine | Solution for injection | 20 mg/ ml | |
hydralazine | Tablet | 50 mg (hydrochloride) | |
hydrochlorothiazide | Tablet (scored) | 25 mg | |
losartan | Tablet | 50mg | |
methyldopa | Tablet | 250 mg | |
sodium nitroprusside | Injection | 10 mg/mL/5 mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
bisoprolol | Tablet | 1.25 mg | |
bisoprolol | Tablet | 2.5 mg | |
bisoprolol | Tablet | 5 mg | |
digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
digoxin | Oral liquid | 50 micrograms/mL | |
digoxin | Tablet | 250 mcg | |
digoxin | Tablet | 62.5 micrograms | |
dobutamine | Injection | 250 mg | |
dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial | |
enalapril | Tablet | 20 mg | |
enalapril | Tablet | 5 mg | |
furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
furosemide | Tablet | 40 mg | |
hydrochlorothiazide | Tablet (scored) | 25 mg | |
losartan | Tablet | 50mg | |
spironolactone | Tablet | 25 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylsalicylic acid | Tablet | 80 mg | |
streptokinase | Powder for injection | 1.5 million IU in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
simvastatin | Tablet | 20 mg | |
simvastatin | Tablet | 40 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
miconazole | Cream | 2% (nitrate) | |
miconazole | Vaginal cream | 2% (nitrate) | |
salicyclic acid + benzoic acid | Cream | 5%/ 5% | |
selenium sulfide | Detergent-based suspension | 2% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
fusidic acid | Ointment | 2% | |
gentian violet | Solution | 1% | |
iodine-povidone | Ointment | 10% | |
iodine-povidone | Solution | 10% | |
mupirocin | Ointment | 2% (nasal ointment) | |
potassium permanganate | Solution | 0.1% | |
silver sulfadiazine | Cream | 1% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
betamethasone | Cream | 0.1% (as valerate) | |
calamine | Lotion | 15% | |
clobetasol | Cream | 0.05% | |
clobetasol | Lotion | 0.05% (propionate) | |
hydrocortisone | Cream | 1% (acetate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
benzoyl peroxide | Gel | 5% | |
coal tar | paste | 5% | |
fluorouracil | Ointment | 5% | |
podophyllum resin | Solution | 10% to 25% | |
salicylic acid | Cream | 10%- 20% | |
salicylic acid | Solution | 5%-10% | |
urea | Cream | 10% | |
urea | Cream | 5% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
benzyl benzoate | Lotion | 25% | |
permethrin | Cream | 5% | |
permethrin | Lotion | 1% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
clindamycin | Solution | 1% | |
methoxsalen | Solution | 0.15% | |
tretinoin | N/A | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
fluorescein | Injection | 50mg/mL (disodium) | |
fluorescein | strips | N/A | |
tropicamide | Solution (eye drops) | 0.5% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
barium sulfate | Powder for enema | 400 g | |
barium sulfate | Powder for oral suspension | 150 g | |
ethyl esters of iodinated fatty acids of poppy oil | Injection | 480 mg/mL | |
iohexol | Injection | 240 mg/mL | |
iopamidol (iopromide) | Intravenous administration | Equiv 300 mg iodine in 20 mL-vial | |
iopamidol (iopromide) | Intravenous administration | Equiv300 mg iodine in 50 mL vial | |
ioxaglic acid | Injection | 320 mg/mL | |
metrizoic acid | Solution | 100mg/L (bladder fluid) | |
metrizoic acid | Solution | 350 mg/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chlorhexidine | mouth wash | 0.2% | |
chlorhexidine | Solution | 0.5% alcohol solution (digluconate) | |
hydrogen peroxide | Solution | 3% | |
iodine-povidone | Solution | 10% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
glutaraldehyde | Solution | 2% | |
sodium hypochlorite | Solution | 0.25% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
furosemide | Tablet | 40 mg | |
hydrochlorothiazide | Tablet (scored) | 25 mg | |
mannitol | Injectable solution | 10% | |
spironolactone | Tablet | 25 mg | |
triamterene | Solid oral dosage form | 50 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aluminum + magnesium hydroxide | Suspension | N/A | |
aluminum + magnesium hydroxide | Tablet | 300mg/ 200mg | |
cimetidine | Injection | 100 mg/mL | |
omeprazole | Tablet | 20 mg | |
omeprazole | Tablet | 40 mg | |
ranitidine | Tablet | 150 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dexamethasone | Tablet | 4 mg | |
dimenhydrinate | Suppository | 10 mg | |
dimenhydrinate | Suppository | 50 mg | |
domperidone | Tablet | 10 mg | |
metoclopramide | Injection | 5 mg (hydrochloride)/mL in 2-mL ampoule | |
ondansetron | Tablet | 4 mg | |
ondansetron | Tablet | 8 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
beclometasone | enema | 3 mg | |
mesalazine | enema | 1G | |
mesalazine | Tablet | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
butyl scopolamine | Injection | 20 mg/ml | |
butyl scopolamine | Tablet | 10mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|